Related Experiment Videos
Magnetic resonance imaging and dexamethasone therapy for bacterial meningitis
M H Lebel1, M J Hoyt, D C Waagner
1Department of Pediatrics, University of Texas Southwestern Medical Center, Southwestern Medical School, Dallas.
Abstract:
We conducted a third placebo-controlled, double-blind study of dexamethasone as adjunctive therapy for bacterial meningitis. Thirty-one patients received cefuroxime sodium (300 mg/kg per day in 3 doses) and dexamethasone phosphate (0.6 mg/kg per day in 4 doses for 4 days), and 29 received cefuroxime and placebo. The groups were comparable at the beginning of therapy. Magnetic resonance imaging performed between days 2 and 5 of therapy was used to assess brain water content indirectly. There were no differences between the 2 treatment groups with respect to the T1- or T2-weighted images. Fifty-two patients (88%) had normal magnetic resonance images; 5 patients had parietal or bifrontal extra-axial fluid collections, and 2 children had areas of abnormal signal intensity in the brain on T2-weighted images. Abnormal findings on magnetic resonance imaging did not alter clinical management, and there was no correlation between the results of magnetic resonance imaging and the outcome of meningitis. The number of patients in this study was too small to determine any statistically significant differences in rates of hearing impairment; however, the cerebrospinal fluid findings and clinical outcome in dexamethasone-treated patients further support the previously reported beneficial effect of corticosteroid treatment in patients with bacterial meningitis.
Insights
Dexamethasone adjunctive therapy for bacterial meningitis showed no MRI differences but supported prior findings of corticosteroid benefits. Further research is needed to confirm effects on hearing impairment.
Area of Science:
- Neurology
- Infectious Diseases
- Pharmacology
Background:
- Bacterial meningitis is a serious infection requiring prompt treatment.
- Adjunctive therapies aim to reduce complications and improve outcomes.
- Dexamethasone has been investigated for its anti-inflammatory effects in meningitis.
Purpose of the Study:
- To evaluate the efficacy of dexamethasone as adjunctive therapy for bacterial meningitis.
- To assess the impact of dexamethasone on brain water content using magnetic resonance imaging (MRI).
- To examine clinical outcomes and hearing impairment rates in patients receiving dexamethasone.
Main Methods:
- A placebo-controlled, double-blind study involving 60 patients with bacterial meningitis.
- Patients received either cefuroxime with dexamethasone or cefuroxime with placebo.
- MRI (T1- and T2-weighted) was performed between days 2-5 to assess brain water content indirectly.
Main Results:
- No significant differences in MRI findings (T1- or T2-weighted images) between dexamethasone and placebo groups.
- 88% of patients had normal MRI scans; abnormalities included fluid collections and signal intensity areas.
- Abnormal MRI findings did not influence clinical management or correlate with meningitis outcome.
Conclusions:
- While MRI showed no differences, dexamethasone treatment supported previous evidence of corticosteroid benefits in bacterial meningitis.
- The study was underpowered to detect statistically significant differences in hearing impairment.
- Cerebrospinal fluid findings and clinical outcomes suggest a beneficial role for corticosteroids.